Truist Financial’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-11,633
Closed -$59.1K 2636
2024
Q1
$59.1K Buy
+11,633
New +$59.1K ﹤0.01% 2567